The Cigna Group
CI
$262.23
-$5.15-1.93%
NYSE
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 5.02B | 5.03B | 3.43B | 3.04B | 3.71B |
Total Depreciation and Amortization | 1.63B | 1.69B | 1.75B | 1.67B | 1.79B |
Total Amortization of Deferred Charges | 1.02B | 1.02B | 1.02B | 1.22B | 1.22B |
Total Other Non-Cash Items | 915.00M | 975.00M | 2.96B | 3.03B | 2.06B |
Change in Net Operating Assets | -3.29B | -1.27B | 1.19B | -2.34B | 616.00M |
Cash from Operations | 5.29B | 7.44B | 10.36B | 6.62B | 9.40B |
Capital Expenditure | -1.35B | -1.43B | -1.41B | -1.43B | -1.44B |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -131.00M | -131.00M | -131.00M | -136.00M | -447.00M |
Divestitures | 2.87B | 2.87B | 521.00M | 0.00 | -14.00M |
Other Investing Activities | -1.96B | -1.71B | -1.09B | -781.00M | -1.01B |
Cash from Investing | -567.00M | -410.00M | -2.10B | -2.35B | -2.91B |
Total Debt Issued | 296.00M | 0.00 | 4.46B | 4.54B | 5.48B |
Total Debt Repaid | -1.54B | -2.42B | -3.40B | -3.00B | -6.35B |
Issuance of Common Stock | 225.00M | 193.00M | 305.00M | 357.00M | 349.00M |
Repurchase of Common Stock | -4.64B | -4.52B | -7.03B | -5.56B | -6.18B |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -1.59B | -1.58B | -1.57B | -1.54B | -1.51B |
Other Financing Activities | -580.00M | -475.00M | -411.00M | -451.00M | -439.00M |
Cash from Financing | -7.82B | -8.80B | -7.65B | -5.65B | -8.66B |
Foreign Exchange rate Adjustments | 27.00M | -2.00M | -20.00M | 20.00M | -5.00M |
Miscellaneous Cash Flow Adjustments | -1.34B | -1.34B | -1.34B | -1.72B | -467.00M |
Net Change in Cash | -4.41B | -3.11B | -745.00M | -3.08B | -2.65B |